Presidio Pharmaceuticals
San Francisco, US
Founders & leadership
PV
Pamela VigExecutive
RC
Richard ColonnoExecutive
NB
Nathaniel BrowninExecutive
ER
Eric RubyExecutive
LL
Leping LiinExecutive
LR
Leo RedmondinExecutive
Board
RW
Robert WilliamsonBoard director
HD
H. Daniel PerezBoard director
SL
Scott LessingBoard director
OH
Omar HaffarBoard director
Reported raises · per SEC filings
Form D private placements$21.8M disclosed across 1 round · 2013
▶$21.8MraisedJun 2014 · 16 investors · PharmaceuticalsRule 506(b)
▶$21.8MraisedJun 2014 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert WilliamsonDirector
- Pamela VigExecutive Officer
- Richard ColonnoExecutive Officer
- Nathaniel BrownExecutive Officer
- Eric RubyExecutive Officer
- Scott LessingDirector
- Leping LiExecutive Officer
- H. Daniel PerezDirector
- Leo RedmondExecutive Officer, Director
- Omar HaffarDirector
- Offering amount
- $22.5M
- Amount sold
- $21.8M
- Proceeds to insiders
- $1M
- First sale
- Apr 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Presidio Pharmaceuticals raised?
- Presidio Pharmaceuticals has disclosed $21.8M raised across 1 round.
- Where is Presidio Pharmaceuticals headquartered?
- Presidio Pharmaceuticals is headquartered in San Francisco, US.